 |
 |
||
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
News / Newsletter |
| Wolf Popper LLP Files Amended Complaint in Maxim Pharmaceuticals Securities Litigation |
|
You must have Adobe Acrobat Reader to view the complaint.
Wolf Popper LLP, as co-lead counsel, filed a Third Amended Class Action Complaint against Maxim Pharmaceuticals in the Southern District of California on May 27, 2003. Click here to view a copy of the Third Amended Class Action Complaint or click on the link above. Investors seeking more information on the litigation may call or email Robert C. Finkel at 212.451.9620 or rfinkel@wolfpopper.com. |
|
__________________________________________________
Home
| Stock Investigation Guide
| Portfolio Monitoring
|
